A pilot study of galunisertib (LY2157299) plus stereotactic body radiotherapy (SBRT) in advanced hepatocellular carcinoma (HCC).

被引：0
|
作者：
Reiss, Kim Anna
Ben-Josef, Edgar
Damjanov, Nevena
Hoteit, Maarouf
O'Hara, Mark H.
Karasic, Thomas Benjamin
Teitelbaum, Ursina R.
Schneider, Charles
O'Dwyer, Peter J.
Carpenter, Erica L.
Mick, Rosemarie
Vonderheide, Robert H.
机构：
[1] Univ Penn, Philadelphia, PA USA
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
[3] Helen F Graham Canc Ctr, Christiana Care Hlth Syst, Newark, DE USA
[4] Univ Penn, Sch Med, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.TPS528
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS528
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A pilot study of galunisertib (LY2157299 monohydrate) plus stereotactic body radiotherapy (SBRT) in advanced hepatocellular carcinoma (HCC).
    Reiss, Kim Anna
    Ben-Josef, Edgar
    Damjanov, Nevena
    Hoteit, Maarouf
    Karasic, Thomas Benjamin
    Carpenter, Erica
    DiCicco, Lisa
    Garcia-Marcano, Luis Anna
    Mick, Rosemarie
    Vonderheide, Robert H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [2] GALUNISERTIB (LY2157299) MODULATES STEMNESS IN HEPATOCELLULAR CARCINOMA
    Rani, B.
    Dituri, F.
    Malfettone, A.
    Cao, Y.
    Lupo, L.
    Fabregat, I.
    Giannelli, G.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S558 - S558
  • [3] A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma
    Reiss, Kim A.
    Wattenberg, Max M.
    Damjanov, Nevena
    Dunphy, Elizabeth Prechtel
    Jacobs-Small, Mona
    Lubas, M. Judy
    Robinson, James
    Dicicco, Lisa
    Garcia-Marcano, Luis
    Giannone, Michael A.
    Karasic, Thomas B.
    Furth, Emma E.
    Carpenter, Erica L.
    Wojcieszynski, Andrzej P.
    Vonderheide, Robert H.
    Beatty, Gregory L.
    Ben-Josef, Edgar
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (02) : 389 - 397
  • [4] Large scale analysis of biomarkers correlated with galunisertib (ly2157299) effectiveness in hepatocellular carcinoma
    Cao, Y.
    Agarwal, R.
    Dituri, F.
    Mancarella, S.
    Rani, B.
    Lupo, L.
    Winter, P.
    Giannelli, G.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 : 33 - 33
  • [5] Outcomes of Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma (HCC)
    Bujold, A.
    Massey, C.
    Kim, J. J.
    Brierley, J. D.
    Cho, C.
    Wong, R.
    Dinniwell, R. E.
    Knox, J. J.
    Sherman, M.
    Dawson, L. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S70 - S71
  • [6] Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma
    Faivre, Sandrine
    Santoro, Armando
    Kelley, Robin K.
    Gane, Ed
    Costentin, Charlotte E.
    Gueorguieva, Ivelina
    Smith, Claire
    Cleverly, Ann
    Lahn, Michael M.
    Raymond, Eric
    Benhadji, Karim A.
    Giannelli, Gianluigi
    LIVER INTERNATIONAL, 2019, 39 (08) : 1468 - 1477
  • [7] Peripheral blood immune correlates associated with TGF-β inhibition (galunisertib) and stereotactic body radiotherapy (SBRT) in patients with advanced hepatocellular carcinoma (HCC).
    Wattenberg, Max Miller
    Reiss, Kim Anna
    Giannone, Michael
    Damjanov, Nevena
    Dunphy, Elizabeth Prechtel
    DiCicco, Lisa
    Garcia-Marcano, Luis
    Karasic, Thomas Benjamin
    Furth, Emma
    Wojcieszynski, Andrzej
    Vonderheide, Robert H.
    Ben-Josef, Edgar
    Beatty, Gregory Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma (HCC): The Indiana University Experience
    Andolino, D. L.
    Maluccio, M.
    Calley, C.
    Kwo, P.
    Tector, A. J.
    Johnstone, P. A. S.
    Cardenes, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S74 - S74
  • [9] Stereotactic body radiotherapy (SBRT) as an alternative to transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)
    Sapir, Eli
    Tao, Yebin
    Parikh, Neehar D.
    Bazzi, Latifa
    Devlin, Pauline
    Novelli, Paula M.
    Cuneo, Kyle Clifford
    Lawrence, Theodore Steven
    Schipper, Matthew J.
    Feng, Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Outcomes following sequential trials of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC).
    Bujold, A.
    Massey, C.
    Kim, J. J.
    Brierley, J. D.
    Wong, R.
    Cho, C.
    Kassam, Z.
    Dinniwell, R. E.
    Ringash, J.
    Cummings, B.
    Knox, J. J.
    Sherman, M.
    Dawson, L. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345